603334.SH
丰倍生物
SSE · Healthcare · Biotechnology · CN
CNY 31.22
−4.44%Aug 23, 2026, 07:32 UTC
Fengbei Biotech announced its H1 2026 results: revenue of 2.347 billion yuan, up 58.76% year-on-year; net profit attributable to shareholders of 81.4251 million yuan, down 4.28% year-on-year.
Source: